ACS CAN Comments on the 340B Drug Pricing Integrity and Affordability for Patients Act Discussion Draft

On August 26, 2026, the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Senate Health, Education, Labor, and Pensions (HELP) Committee on the 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft.

We offered comments on the following proposals:

• Section 4. Additional Definitions
• Section 6. Transparency
• Section 7. Enhancing Affordability
• Section 9. Contracting Reforms
• Section 12. Application; Regulations and Guidance